Literature DB >> 9186882

Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study.

L G Hunsicker1, S Adler, A Caggiula, B K England, T Greene, J W Kusek, N L Rogers, P E Teschan.   

Abstract

The Modification of Diet in Renal Disease (MDRD) Study examined the effects of dietary protein restriction and strict blood pressure control on the decline in glomerular filtration rate (GFR) in 840 patients with diverse renal diseases. We describe a systematic analysis to determine baseline factors that predict the decline in GFR, or which alter the efficacy of the diet or blood pressure interventions. Univariate analysis identified 18 of 41 investigated baseline factors as significant (P < 0.05) predictors of GFR decline. In multivariate analysis, six factors--greater urine protein excretion, diagnosis of polycystic kidney disease (PKD), lower serum transferrin, higher mean arterial pressure, black race, and lower serum HDL cholesterol--independently predicted a faster decline in GFR. Together with the study interventions, these six factors accounted for 34.5% and 33.9% of the variance between patients in GFR slopes in Studies A and B, respectively, with proteinuria and PKD playing the predominant role. The mean rate of GFR decline was not significantly related to baseline GFR, suggesting an approximately linear mean GFR decline as renal disease progresses. The 41 baseline predictors were also assessed for their interactions with the diet and blood pressure interventions. A greater benefit of the low blood pressure intervention was found in patients with higher baseline urine protein. None of the 41 baseline factors were shown to predict a greater or lesser effect of dietary protein restriction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9186882     DOI: 10.1038/ki.1997.260

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  187 in total

1.  Sex-Related Disparities in CKD Progression.

Authors:  Ana C Ricardo; Wei Yang; Daohang Sha; Lawrence J Appel; Jing Chen; Marie Krousel-Wood; Anjella Manoharan; Susan Steigerwalt; Jackson Wright; Mahboob Rahman; Sylvia E Rosas; Milda Saunders; Kumar Sharma; Martha L Daviglus; James P Lash
Journal:  J Am Soc Nephrol       Date:  2018-12-03       Impact factor: 10.121

2.  Kidney function can improve in patients with hypertensive CKD.

Authors:  Bo Hu; Crystal Gadegbeku; Michael S Lipkowitz; Stephen Rostand; Julia Lewis; Jackson T Wright; Lawrence J Appel; Tom Greene; Jennifer Gassman; Brad C Astor
Journal:  J Am Soc Nephrol       Date:  2012-03-08       Impact factor: 10.121

3.  Improvement in kidney function: a real occurrence.

Authors:  Tanvir Chowdhury Turin; Brenda R Hemmelgarn
Journal:  J Am Soc Nephrol       Date:  2012-03-08       Impact factor: 10.121

4.  Very low but stable glomerular filtration rate after living kidney donation: is the concept of "chronic kidney disease" applicable to kidney donors?

Authors:  Ryo Kido; Yugo Shibagaki; Kazuhiro Iwadoh; Ichiro Nakajima; Shohei Fuchinoue; Toshiro Fujita; Satoshi Teraoka
Journal:  Clin Exp Nephrol       Date:  2010-03-26       Impact factor: 2.801

5.  Natural history of older adults with impaired kidney function: the InCHIANTI study.

Authors:  Sandra V Giannelli; Christophe E Graf; François R Herrmann; Jean-Pierre Michel; Kushang V Patel; Francesco Pizzarelli; Luigi Ferrucci; Jack Guralnik
Journal:  Rejuvenation Res       Date:  2011-09-28       Impact factor: 4.663

6.  Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.

Authors:  Davide Bolignano; Antonio Lacquaniti; Giuseppe Coppolino; Valentina Donato; Susanna Campo; Maria Rosaria Fazio; Giacomo Nicocia; Michele Buemi
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-28       Impact factor: 8.237

7.  Longitudinal lipid trends and adverse outcomes in patients with CKD: a 13-year observational cohort study.

Authors:  Ching-Wei Tsai; Han-Chun Huang; Hsiu-Yin Chiang; Chih-Wei Chung; Shih-Ni Chang; Pei-Lun Chu; Chin-Chi Kuo
Journal:  J Lipid Res       Date:  2019-01-14       Impact factor: 5.922

Review 8.  Appropriate drug therapy for improving outcomes in diabetic nephropathy.

Authors:  Robert D Toto
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

9.  Black Americans' Perspectives of Barriers and Facilitators of Community Screening for Kidney Disease.

Authors:  Ebele M Umeukeje; Marcus G Wild; Saugar Maripuri; Teresa Davidson; Margaret Rutherford; Khaled Abdel-Kader; Julia Lewis; Consuelo H Wilkins; Kerri Cavanaugh
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-15       Impact factor: 8.237

10.  Disorders of lipid metabolism and chronic kidney disease in the elderly.

Authors:  Devasmita Choudhury; Meryem Tuncel; Moshe Levi
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.